Your browser doesn't support javascript.
loading
APOE4 dysregulates autophagy in cultured cells.
Fote, Gianna M; Steffan, Joan S.
Afiliação
  • Fote GM; Department of Biological Chemistry, University of California, Irvine, Irvine, California, USA.
  • Steffan JS; Department of Psychiatry and Human Behavior, and UCI MIND Institute, University of California, Irvine, Irvine, California, USA.
Autophagy Rep ; 1(1): 29-33, 2022.
Article em En | MEDLINE | ID: mdl-38912292
ABSTRACT
Human APOE4 (apolipoprotein E4 isoform) is a powerful genetic risk factor for late-onset Alzheimer disease (AD). Many groups have investigated the effect of APOE4 on the degradation of amyloid ß (Aß), the main component of plaques found in the brains of AD patients. However, few studies have focused on the degradation of APOE itself. We investigated the lysosomal trafficking of APOE in cells and found that APOE from the post-Golgi compartment is degraded through an autophagic process requiring the lysosomal membrane protein LAMP2A. We found that APOE4 accumulates in enlarged lysosomes, alters autophagic flux, and changes the proteomic contents of lysosomes following internalization. This dysregulated lysosomal trafficking may represent one of the mechanisms that contributes to AD pathogenesis.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos